Sanjeev Luther
Sanjeev Luther is President and CEO of Ernexa Therapeutics and a member of the Board of Directors. Sanjeev is a seasoned pharmaceutical executive with over 30 years in leadership roles at organisations including Cornerstone Pharmaceuticals, Bristol Myers Squibb, Novartis, Bausch and Lomb, and GE Healthcare. Ernexa Therapeutics is developing innovative cell therapies for the treatment of advanced cancer and autoimmune disease.
ArticleSynthetic iMSCs: reprogramming ovarian cancer from the inside out
Ovarian cancer has long proved difficult to treat. Could the answer lie within the disease itself? Discover how synthetic iMSCs could reprogramme the tumour microenvironment and restore anti-tumour immunity.